semaglutide gi obstruction lawsuit in louisiana bowel class action west virginia Wegovy Lawyer Patients claim blindness, bowel injuries

The positive phase 1 clinical trial for Viking Therapeutics Inc

Recent breakthroughs highlighted the dramatic effect of GLP-1RAs and related pharmaceuticals in reversing the effects imposed by metabolic syndrome on cardiovascular health.

So for people with Type 2 diabetes or obesity-linked metabolic disease, this could be life-changing

Research evaluating whether the GLP-1 receptor agonist semaglutide is superior to placebo in reducing body weight and knee osteoarthritis pain...

GLP-1 is a hormone that the gut produces after eating to regulate blood sugar, slow digestion and manage hunger

Learn how these FDA-approved medications work, what to expect during dose escalation, and how to optimize results with lifestyle changes for diabetes and weight management.